New £800-a-dose jab offers hope for diabetics suffering macular oedema

Brolucizumab treats fluid build-up in the eyes – called diabetic macular oedema – that can lead to blurred vision and, eventually, loss of sight.Brolucizumab treats fluid build-up in the eyes – called diabetic macular oedema – that can lead to blurred vision and, eventually, loss of sight.Read MoreHealth News | Mail Online